Nanobiotix S.A. Gains 46.98%
Mon, Aug 01, 2022 at 06:47 PM
Nanobiotix S.A. (NBTX:NASDAQ) soared at $3.41, representing a gain of 47%. The stock appeared on our News Catalysts scanner on Wed, Jul 13, 2022 at 05:05 PM in the 'AGREEMENT' category. From Mon, Jul 18, 2022, the stock recorded 66.67% Up Days and 60.00% Green Days
About Nanobiotix S.A. (NBTX:NASDAQ)
Nanobiotix SA is a clinical-stage biotechnology company that focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy...
Top 10 Gainers:
- Virax Biolabs Group Limited (VRAX:NASDAQ), 119.44%
- Ontrak Inc. (OTRK:NASDAQ), 107.69%
- Revlon, Inc. (REV:NYSE), 89.93%
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 85.38%
- Mediaco Holding Inc. (MDIA:NASDAQ), 60.87%
- Nanobiotix S.A. (NBTX:NASDAQ), 46.98%
- Celyad SA (CYAD:NASDAQ), 40.8%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 38%
- TherapeuticsMD, Inc. (TXMD:NASDAQ), 36.6%
- MAIA Biotechnology Inc. (MAIA:NYSEMKT), 34.48%